← Back to guidelines
Cardiology14 papers

Nondiabetic gastroparesis

Last edited: 4/15/2026

Overview

Nondiabetic gastroparesis is a functional gastrointestinal disorder characterized by delayed gastric emptying without diabetes, leading to symptoms such as nausea, vomiting, bloating, early satiety, and abdominal pain 2.

Diagnosis

  • Key Symptoms: Nausea, vomiting, bloating, early satiety, abdominal pain 2.
  • Primary Diagnostic Test: Gastric scintigraphy 2.
  • Alternative Diagnostic Modalities: Breath test, capsule endoscopy, ultrasound, MRI, single photon emission CT imaging 2.
  • Management

  • First-Line Treatments:
  • - Antiemetics: Ondansetron, promethazine (specific doses not detailed in abstracts) 2. - Nutritional Support: Dietary modifications, including small, frequent meals 2.
  • Adjunctive Treatments:
  • - Prokinetic Agents: Metoclopramide (specific doses not detailed in abstracts) 2. - Pain Control: Analgesics as needed for abdominal pain 2. - Gastric Stimulation: For refractory cases with severe nausea and vomiting 2.

    Special Populations

  • Pregnancy: Not specifically addressed in provided abstracts [].
  • Pediatrics: Not specifically addressed in provided abstracts [].
  • Elderly: Not specifically addressed in provided abstracts [].
  • Comorbidities: Management considerations may include addressing coexisting conditions like irritable bowel syndrome, but specific guidance not detailed 2.
  • Key Recommendations

  • Utilize gastric scintigraphy as the primary diagnostic tool for nondiabetic gastroparesis (Evidence: Moderate) 2.
  • Implement dietary modifications focusing on small, frequent meals alongside antiemetic therapy for symptom management (Evidence: Moderate) 2.
  • Consider prokinetic agents for patients with persistent symptoms despite initial management, though specific dosing should be individualized (Evidence: Moderate) 2.
  • References

    1 Koch KL, Hasler WL, Van Natta M, Calles-Escandon J, Grover M, Pasricha PJ et al.. Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity. Neurogastroenterology and motility 2020. link 2 Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010. link

    Original source

    1. [1]
      Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity.Koch KL, Hasler WL, Van Natta M, Calles-Escandon J, Grover M, Pasricha PJ et al. Neurogastroenterology and motility (2020)
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG